Exagen, Inc. (XGN)
8.17
+0.28
(+3.55%)
USD |
NASDAQ |
Oct 02, 16:00
8.14
-0.03
(-0.37%)
After-Hours: 20:00
Exagen Net Income (Quarterly) : -3.196M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.196M |
| March 31, 2026 | -3.967M |
| December 31, 2025 | -4.673M |
| September 30, 2025 | -7.087M |
| June 30, 2025 | -4.439M |
| March 31, 2025 | -3.752M |
| December 31, 2024 | -3.761M |
| September 30, 2024 | -5.028M |
| June 30, 2024 | -2.966M |
| March 31, 2024 | -3.36M |
| December 31, 2023 | -5.573M |
| September 30, 2023 | -5.415M |
| June 30, 2023 | -5.013M |
| March 31, 2023 | -7.688M |
| December 31, 2022 | -14.35M |
| September 30, 2022 | -8.096M |
| June 30, 2022 | -14.66M |
| March 31, 2022 | -10.27M |
| December 31, 2021 | -7.053M |
| September 30, 2021 | -7.179M |
| June 30, 2021 | -6.41M |
| March 31, 2021 | -6.209M |
| December 31, 2020 | -3.453M |
| Date | Value |
|---|---|
| September 30, 2020 | -4.308M |
| June 30, 2020 | -3.363M |
| March 31, 2020 | -5.563M |
| December 31, 2019 | -3.408M |
| September 30, 2019 | -16.74M |
| June 30, 2019 | -2.785M |
| March 31, 2019 | -2.704M |
| December 31, 2018 | -1.317M |
| September 30, 2018 | -1.756M |
| June 30, 2018 | -2.146M |
| March 31, 2018 | -3.945M |
| December 31, 2015 | -2.533M |
| September 30, 2015 | -3.506M |
| June 30, 2015 | -9.686M |
| March 31, 2015 | -3.458M |
| December 31, 2014 | -1.303M |
| September 30, 2014 | -4.813M |
| June 30, 2014 | -3.992M |
| March 31, 2014 | -3.567M |
| December 31, 2013 | -6.457M |
| September 30, 2013 | -2.433M |
| June 30, 2013 | -2.321M |
| March 31, 2013 | -2.285M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -43.20M |
| BioRestorative Therapies, Inc. | -2.154M |
| CareDx, Inc. | 110.64M |
| Natera, Inc. | -66.97M |
| Sera Prognostics, Inc. | -9.139M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 19.94M |
| Total Expenses (Quarterly) | 23.14M |
| EPS Diluted (Quarterly) | -0.1323 |
| Enterprise Value | 200.73M |
| Gross Profit Margin (Quarterly) | 61.27% |
| Profit Margin (Quarterly) | -16.03% |
| Earnings Yield | -9.86% |
| Normalized Earnings Yield | -9.361 |